J Bayliss

1.7k total citations
25 papers, 1.3k citations indexed

About

J Bayliss is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J Bayliss has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J Bayliss's work include Heart Failure Treatment and Management (7 papers), Cardiac Imaging and Diagnostics (4 papers) and Cardiovascular and exercise physiology (4 papers). J Bayliss is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiac Imaging and Diagnostics (4 papers) and Cardiovascular and exercise physiology (4 papers). J Bayliss collaborates with scholars based in United Kingdom, Bulgaria and United States. J Bayliss's co-authors include G C Sutton, P A Poole-Wilson, M S Norell, R Canepa‐Anson, Jayan Parameshwar, A. Richardson, A. Scriven, George C. Sutton, J E Roulston and Nirmala D. Markandu and has published in prestigious journals such as The Lancet, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

J Bayliss

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Bayliss United Kingdom 16 858 211 207 149 148 25 1.3k
G C Sutton United Kingdom 13 724 0.8× 201 1.0× 125 0.6× 154 1.0× 90 0.6× 25 1.1k
William E. Harston United States 8 1.7k 2.0× 170 0.8× 222 1.1× 98 0.7× 121 0.8× 11 1.9k
H Vetter Germany 16 776 0.9× 141 0.7× 373 1.8× 134 0.9× 128 0.9× 58 1.4k
Lawrence Laslett United States 14 518 0.6× 103 0.5× 253 1.2× 76 0.5× 98 0.7× 39 981
Isabelle Antony France 18 953 1.1× 164 0.8× 223 1.1× 251 1.7× 118 0.8× 39 1.5k
K. H. Rahn Germany 18 603 0.7× 231 1.1× 172 0.8× 123 0.8× 108 0.7× 56 1.2k
A. H. Henderson United Kingdom 22 763 0.9× 311 1.5× 479 2.3× 421 2.8× 120 0.8× 47 1.7k
Steven M. Zeldis United States 12 1.6k 1.8× 235 1.1× 308 1.5× 89 0.6× 345 2.3× 17 2.0k
Allen B. Weisse United States 22 908 1.1× 215 1.0× 350 1.7× 82 0.6× 102 0.7× 74 1.6k
Catherine N. Marti United States 13 709 0.8× 118 0.6× 98 0.5× 116 0.8× 116 0.8× 24 982

Countries citing papers authored by J Bayliss

Since Specialization
Citations

This map shows the geographic impact of J Bayliss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Bayliss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Bayliss more than expected).

Fields of papers citing papers by J Bayliss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Bayliss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Bayliss. The network helps show where J Bayliss may publish in the future.

Co-authorship network of co-authors of J Bayliss

This figure shows the co-authorship network connecting the top 25 collaborators of J Bayliss. A scholar is included among the top collaborators of J Bayliss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Bayliss. J Bayliss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallace, I. R., J Bayliss, Andrew J. Brown, et al.. (2023). CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imaging. Toxicological Sciences. 195(1). 61–70. 6 indexed citations
2.
Beresford, Bryony, Faith Gibson, J Bayliss, & Suzanne Mukherjee. (2016). Preventing work-related stress among staff working in children's cancer Principal Treatment Centres in the UK: a brief survey of staff support systems and practices. European Journal of Cancer Care. 27(2). e12535–e12535. 13 indexed citations
3.
Bayliss, J, et al.. (2015). The treatment of deep infection by intraoperative manufacture of removable, antibiotic impregnated bead strings. Annals of The Royal College of Surgeons of England. 97(5). 399b–399.
4.
Wong, Tien Yin, et al.. (2009). Antipsychotic-drug-induced dilated cardiomyopathy. BMJ Case Reports. 2009. bcr0920080958–bcr0920080958. 2 indexed citations
5.
Kojodjojo, Pipin, Diane Barker, Pouya Youssefi, et al.. (2008). Outcomes of elderly patients aged 80 and over with symptomatic, severe aortic stenosis: impact of patient's choice of refusing aortic valve replacement on survival. QJM. 101(7). 567–573. 55 indexed citations
6.
Underwood, S. Richard, et al.. (2002). Measurement of left ventricular volume after anterior myocardial infarction: comparison of magnetic resonance imaging, echocardiography, and radionuclide ventriculography. International journal of cardiac imaging. 18(2). 135–142. 19 indexed citations
7.
Urban, Philippe, N P Buller, K. Fox, et al.. (1988). Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty.. Heart. 60(6). 485–488. 72 indexed citations
8.
Kenny, Rose Anne, Calum C. Lyon, A. Ingram, et al.. (1987). Enhanced vagal activity and normal arginine vasopressin response in carotid sinus syndrome: implications for a central abnormality in carotid sinus hypersensitivity. Cardiovascular Research. 21(7). 545–550. 15 indexed citations
9.
Richardson, A., A. Scriven, P A Poole-Wilson, et al.. (1987). DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE. The Lancet. 330(8561). 709–711. 320 indexed citations
10.
Bayliss, J, M S Norell, R Canepa‐Anson, G C Sutton, & P A Poole-Wilson. (1987). Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.. Heart. 57(1). 17–22. 374 indexed citations
11.
Bayliss, J, R Canepa‐Anson, M S Norell, P POOLEWILSON, & George C. Sutton. (1986). Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.. Heart. 55(3). 265–273. 20 indexed citations
12.
Bayliss, J, R Canepa‐Anson, M S Norell, PA Poole-Wilson, & G C Sutton. (1986). The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin. European Heart Journal. 7(10). 877–884. 6 indexed citations
14.
Canepa‐Anson, R, J Bayliss, G C Sutton, & PA Poole-Wilson. (1985). Assessment of Dynamic Cardiac Reserve for the Prediction of the Ventricular Response to Vasodilator Therapy in Heart Failure. Clinical Science. 68(s11). 31P–31P. 1 indexed citations
16.
Bayliss, J, et al.. (1983). Bedside haemodynamic monitoring: experience in a general hospital.. BMJ. 287(6386). 187–190. 21 indexed citations
17.
Bayliss, J, et al.. (1983). Ventricular dysrhythmias following intravenous dipyridamole during “stress” myocardial imaging. British Journal of Radiology. 56(669). 686–686. 28 indexed citations
18.
Bayliss, J, M S Norell, R Canepa‐Anson, et al.. (1983). Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.. Heart. 49(3). 214–221. 16 indexed citations
19.
Bayliss, J, M S Norell, R Canepa‐Anson, et al.. (1982). Comparison of amrinone and pirbuterol in chronic heart failure: Additive effect of isosorbide dinitpate. The American Journal of Cardiology. 49(4). 1039–1039. 1 indexed citations
20.
Bayliss, J, et al.. (1982). Clinical studies with beta 2 adrenoceptor agonists in heart failure.. PubMed. 3 Suppl D. 135–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026